{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T22:31:10Z","timestamp":1793399470060,"version":"4.5.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100010041","name":"Tianjin Municipal Science and Technology Committee","doi-asserted-by":"publisher","award":["23 JCZDJC01040"],"award-info":[{"award-number":["23 JCZDJC01040"]}],"id":[{"id":"10.13039\/501100010041","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"DOI":"10.1007\/s40618-026-02988-z","type":"journal-article","created":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T05:41:00Z","timestamp":1784526060000},"page":"3419-3431","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effects of vitamin D status and supplementation on MASLD severity in individuals with overweight or obesity: a cross-sectional study and randomized controlled trial"],"prefix":"10.1007","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-4378-9703","authenticated-orcid":false,"given":"Lulu","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1006-4329","authenticated-orcid":false,"given":"Xincheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-0151-4627","authenticated-orcid":false,"given":"Xiaotian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3656-839X","authenticated-orcid":false,"given":"Xiaojuan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-2150-9810","authenticated-orcid":false,"given":"Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4857-8146","authenticated-orcid":false,"given":"Chunjun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4216-6968","authenticated-orcid":false,"given":"Tao","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,20]]},"reference":[{"issue":"4","key":"2988_CR1","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1136\/gutjnl-2023-330595","volume":"73","author":"G Targher","year":"2024","unstructured":"Targher G, Byrne CD, Tilg H (2024) MASLD: a systemic metabolic disorder with cardiovascular and malignant complications. Gut 73(4):691\u2013702. https:\/\/doi.org\/10.1136\/gutjnl-2023-330595","journal-title":"Gut"},{"issue":"5","key":"2988_CR2","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1097\/hep.0000000000000670","volume":"79","author":"F Kanwal","year":"2024","unstructured":"Kanwal F, Neuschwander-Tetri BA, Loomba R, Rinella ME (2024) Metabolic dysfunction-associated steatotic liver disease: Update and impact of new nomenclature on the American Association for the Study of Liver Diseases practice guidance on nonalcoholic fatty liver disease. Hepatology 79(5):1212\u20131219. https:\/\/doi.org\/10.1097\/hep.0000000000000670","journal-title":"Hepatology"},{"issue":"5","key":"2988_CR3","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1002\/hep.31150","volume":"71","author":"J Zhou","year":"2020","unstructured":"Zhou J, Zhou F, Wang W, Zhang XJ, Ji YX, Zhang P, She ZG, Zhu L, Cai J, Li H (2020) Epidemiological Features of NAFLD From 1999 to 2018 in China. Hepatology 71(5):1851\u20131864. https:\/\/doi.org\/10.1002\/hep.31150","journal-title":"Hepatology"},{"issue":"3","key":"2988_CR4","doi-asserted-by":"publisher","first-page":"e573","DOI":"10.1016\/j.cgh.2021.02.030","volume":"20","author":"J Liu","year":"2022","unstructured":"Liu J, Ayada I, Zhang X, Wang L, Li Y, Wen T, Ma Z, Bruno MJ, de Knegt RJ, Cao W, Peppelenbosch MP, Ghanbari M, Li Z, Pan Q (2022) Estimating Global Prevalence of Metabolic Dysfunction-Associated Fatty Liver Disease in Overweight or Obese Adults. Clin Gastroenterol Hepatol 20(3):e573\u2013e582. https:\/\/doi.org\/10.1016\/j.cgh.2021.02.030","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"11","key":"2988_CR5","doi-asserted-by":"publisher","first-page":"3390","DOI":"10.1111\/dom.15238","volume":"25","author":"K Chen","year":"2023","unstructured":"Chen K, Shen Z, Gu W, Lyu Z, Qi X, Mu Y, Ning Y (2023) Prevalence of obesity and associated complications in China: A cross-sectional, real-world study in 15.8 million adults. Diabetes Obes Metab 25(11):3390\u20133399. https:\/\/doi.org\/10.1111\/dom.15238","journal-title":"Diabetes Obes Metab"},{"issue":"1","key":"2988_CR6","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/s2468-1253(22)00317-x","volume":"8","author":"J Quek","year":"2023","unstructured":"Quek J, Chan KE, Wong ZY, Tan C, Tan B, Lim WH, Tan DJH, Tang ASP, Tay P, Xiao J, Yong JN, Zeng RW, Chew NWS, Nah B, Kulkarni A, Siddiqui MS, Dan YY, Wong VW, Sanyal AJ, Noureddin M, Muthiah M, Ng CH (2023) Global prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in the overweight and obese population: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol 8(1):20\u201330. https:\/\/doi.org\/10.1016\/s2468-1253(22)00317-x","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"5","key":"2988_CR7","doi-asserted-by":"publisher","first-page":"e1135","DOI":"10.1016\/j.cgh.2021.06.042","volume":"20","author":"W Sohn","year":"2022","unstructured":"Sohn W, Kwon HJ, Chang Y, Ryu S, Cho YK (2022) Liver fibrosis in Asians with metabolic dysfunction-associated fatty liver disease. Clin Gastroenterol Hepatol 20(5):e1135\u2013e1148. https:\/\/doi.org\/10.1016\/j.cgh.2021.06.042","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"2988_CR8","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.jhep.2024.04.031","volume":"81","author":"EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)","year":"2024","unstructured":"EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD) (2024) J Hepatol 81(3):492\u2013542. https:\/\/doi.org\/10.1016\/j.jhep.2024.04.031","journal-title":"J Hepatol"},{"issue":"7","key":"2988_CR9","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/s2468-1253(23)00066-3","volume":"8","author":"MA Tincopa","year":"2023","unstructured":"Tincopa MA, Loomba R (2023) Non-invasive diagnosis and monitoring of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis. Lancet Gastroenterol Hepatol 8(7):660\u2013670. https:\/\/doi.org\/10.1016\/s2468-1253(23)00066-3","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"10464","key":"2988_CR10","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1016\/s0140-6736(24)01811-7","volume":"404","author":"M Israelsen","year":"2024","unstructured":"Israelsen M, Francque S, Tsochatzis EA, Krag A (2024) Steatotic liver disease. Lancet 404(10464):1761\u20131778. https:\/\/doi.org\/10.1016\/s0140-6736(24)01811-7","journal-title":"Lancet"},{"issue":"4","key":"2988_CR11","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1111\/obr.12239","volume":"16","author":"M Pereira-Santos","year":"2015","unstructured":"Pereira-Santos M, Costa PR, Assis AM, Santos CA, Santos DB (2015) Obesity and vitamin D deficiency: a systematic review and meta-analysis. Obes Rev 16(4):341\u2013349. https:\/\/doi.org\/10.1111\/obr.12239","journal-title":"Obes Rev"},{"issue":"4","key":"2988_CR12","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.3945\/ajcn.116.136879","volume":"104","author":"SR Mallard","year":"2016","unstructured":"Mallard SR, Howe AS, Houghton LA (2016) Vitamin D status and weight loss: a systematic review and meta-analysis of randomized and nonrandomized controlled weight-loss trials. Am J Clin Nutr 104(4):1151\u20131159. https:\/\/doi.org\/10.3945\/ajcn.116.136879","journal-title":"Am J Clin Nutr"},{"issue":"6","key":"2988_CR13","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1136\/gutjnl-2017-313884","volume":"66","author":"LA Adams","year":"2017","unstructured":"Adams LA, Anstee QM, Tilg H, Targher G (2017) Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases. Gut 66(6):1138\u20131153. https:\/\/doi.org\/10.1136\/gutjnl-2017-313884","journal-title":"Gut"},{"issue":"9","key":"2988_CR14","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1111\/dom.14774","volume":"24","author":"ID Vachliotis","year":"2022","unstructured":"Vachliotis ID, Anastasilakis AD, Goulas A, Goulis DG, Polyzos SA (2022) Nonalcoholic fatty liver disease and osteoporosis: A potential association with therapeutic implications. Diabetes Obes Metab 24(9):1702\u20131720. https:\/\/doi.org\/10.1111\/dom.14774","journal-title":"Diabetes Obes Metab"},{"issue":"5","key":"2988_CR15","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1002\/hep.30937","volume":"71","author":"B Dong","year":"2020","unstructured":"Dong B, Zhou Y, Wang W, Scott J, Kim K, Sun Z, Guo Q, Lu Y, Gonzales NM, Wu H, Hartig SM, York RB, Yang F, Moore DD (2020) Vitamin D receptor activation in liver macrophages ameliorates hepatic inflammation, steatosis, and insulin resistance in mice. Hepatology 71(5):1559\u20131574. https:\/\/doi.org\/10.1002\/hep.30937","journal-title":"Hepatology"},{"issue":"5","key":"2988_CR16","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1210\/endrev\/bnae009","volume":"45","author":"A Giustina","year":"2024","unstructured":"Giustina A, Bilezikian JP, Adler RA, Banfi G, Bikle DD, Binkley NC, Bollerslev J, Bouillon R, Brandi ML, Casanueva FF, di Filippo L, Donini LM, Ebeling PR, Fuleihan GE, Fassio A, Frara S, Jones G, Marcocci C, Martineau AR, Minisola S, Napoli N, Procopio M, Rizzoli R, Schafer AL, Sempos CT, Ulivieri FM, Virtanen JK (2024) Consensus statement on vitamin D status assessment and supplementation: Whys, Whens, and Hows. Endocr Rev 45(5):625\u2013654. https:\/\/doi.org\/10.1210\/endrev\/bnae009","journal-title":"Endocr Rev"},{"issue":"1","key":"2988_CR17","doi-asserted-by":"publisher","first-page":"e2250681","DOI":"10.1001\/jamanetworkopen.2022.50681","volume":"6","author":"DK Tobias","year":"2023","unstructured":"Tobias DK, Luttmann-Gibson H, Mora S, Danik J, Bubes V, Copeland T, LeBoff MS, Cook NR, Lee IM, Buring JE, Manson JE (2023) Association of body weight with response to vitamin D supplementation and metabolism. JAMA Netw Open 6(1):e2250681. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.50681","journal-title":"JAMA Netw Open"},{"issue":"1","key":"2988_CR18","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s11154-019-09527-7","volume":"21","author":"LF de Oliveira","year":"2020","unstructured":"de Oliveira LF, de Azevedo LG, da Mota Santana J, de Sales LPC, Pereira-Santos M (2020) Obesity and overweight decreases the effect of vitamin D supplementation in adults: systematic review and meta-analysis of randomized controlled trials. Rev Endocr Metab Disord 21(1):67\u201376. https:\/\/doi.org\/10.1007\/s11154-019-09527-7","journal-title":"Rev Endocr Metab Disord"},{"issue":"2","key":"2988_CR19","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.cgh.2022.01.021","volume":"21","author":"S Yuan","year":"2023","unstructured":"Yuan S, Larsson SC (2023) Inverse Association between serum 25-hydroxyvitamin D and nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol 21(2):398\u2013405e394. https:\/\/doi.org\/10.1016\/j.cgh.2022.01.021","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"2988_CR20","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1093\/ajcn\/nqac260","volume":"116","author":"JJ Zhang","year":"2022","unstructured":"Zhang JJ, Yu HC, Li Y, Zhang YB, Geng TT, Lu Q, Liao YF, Guo KQ, Du L, Ruan HL, Yang K, Liu G, Pan A (2022) Association between serum 25-hydroxy vitamin D concentrations and mortality among individuals with metabolic dysfunction-associated fatty liver disease: a prospective cohort study. Am J Clin Nutr 116(5):1409\u20131417. https:\/\/doi.org\/10.1093\/ajcn\/nqac260","journal-title":"Am J Clin Nutr"},{"issue":"6","key":"2988_CR21","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1038\/ajg.2016.51","volume":"111","author":"JE Nelson","year":"2016","unstructured":"Nelson JE, Roth CL, Wilson LA, Yates KP, Aouizerat B, Morgan-Stevenson V, Whalen E, Hoofnagle A, Mason M, Gersuk V, Yeh MM, Kowdley KV (2016) Vitamin D deficiency is associated with increased risk of non-alcoholic steatohepatitis in adults with non-alcoholic fatty liver disease: possible role for MAPK and NF-\u03baB? Am J Gastroenterol 111(6):852\u2013863. https:\/\/doi.org\/10.1038\/ajg.2016.51","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"2988_CR22","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.jhep.2014.08.040","volume":"62","author":"F Bril","year":"2015","unstructured":"Bril F, Maximos M, Portillo-Sanchez P, Biernacki D, Lomonaco R, Subbarayan S, Correa M, Lo M, Suman A, Cusi K (2015) Relationship of vitamin D with insulin resistance and disease severity in non-alcoholic steatohepatitis. J Hepatol 62(2):405\u2013411. https:\/\/doi.org\/10.1016\/j.jhep.2014.08.040","journal-title":"J Hepatol"},{"issue":"3","key":"2988_CR23","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1007\/s13679-024-00574-z","volume":"13","author":"F Abdelhameed","year":"2024","unstructured":"Abdelhameed F, Kite C, Lagojda L, Dallaway A, Chatha KK, Chaggar SS, Dalamaga M, Kassi E, Kyrou I, Randeva HS (2024) Non-invasive scores and serum biomarkers for fatty liver in the era of metabolic dysfunction-associated steatotic liver disease (MASLD): A Comprehensive Review From NAFLD to MAFLD and MASLD. Curr Obes Rep 13(3):510\u2013531. https:\/\/doi.org\/10.1007\/s13679-024-00574-z","journal-title":"Curr Obes Rep"},{"issue":"6","key":"2988_CR24","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1053\/j.gastro.2019.01.042","volume":"156","author":"PJ Eddowes","year":"2019","unstructured":"Eddowes PJ, Sasso M, Allison M, Tsochatzis E, Anstee QM, Sheridan D, Guha IN, Cobbold JF, Deeks JJ, Paradis V, Bedossa P, Newsome PN (2019) Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease. Gastroenterology 156(6):1717\u20131730. https:\/\/doi.org\/10.1053\/j.gastro.2019.01.042","journal-title":"Gastroenterology"},{"issue":"11","key":"2988_CR25","doi-asserted-by":"publisher","first-page":"955","DOI":"10.14218\/jcth.2024.00311","volume":"12","author":"JG Fan","year":"2024","unstructured":"Fan JG, Xu XY, Yang RX, Nan YM, Wei L, Jia JD, Zhuang H, Shi JP, Li XY, Sun C, Li J, Wong VW, Duan ZP (2024) Guideline for the Prevention and Treatment of Metabolic Dysfunction-associated Fatty Liver Disease (Version 2024). J Clin Transl Hepatol 12(11):955\u2013974. https:\/\/doi.org\/10.14218\/jcth.2024.00311","journal-title":"J Clin Transl Hepatol"},{"issue":"1","key":"2988_CR26","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","volume":"73","author":"M Eslam","year":"2020","unstructured":"Eslam M, Newsome PN, Sarin SK, Anstee QM, Targher G, Romero-Gomez M, Zelber-Sagi S, Wai-Sun Wong V, Dufour JF, Schattenberg JM, Kawaguchi T, Arrese M, Valenti L, Shiha G, Tiribelli C, Yki-J\u00e4rvinen H, Fan JG, Gr\u00f8nb\u00e6k H, Yilmaz Y, Cortez-Pinto H, Oliveira CP, Bedossa P, Adams LA, Zheng MH, Fouad Y, Chan WK, Mendez-Sanchez N, Ahn SH, Castera L, Bugianesi E, Ratziu V, George J (2020) A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement. J Hepatol 73(1):202\u2013209. https:\/\/doi.org\/10.1016\/j.jhep.2020.03.039","journal-title":"J Hepatol"},{"issue":"5","key":"2988_CR27","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1016\/j.jhep.2016.12.022","volume":"66","author":"T Karlas","year":"2017","unstructured":"Karlas T, Petroff D, Sasso M, Fan JG, Mi YQ, de L\u00e9dinghen V, Kumar M, Lupsor-Platon M, Han KH, Cardoso AC, Ferraioli G, Chan WK, Wong VW, Myers RP, Chayama K, Friedrich-Rust M, Beaugrand M, Shen F, Hiriart JB, Sarin SK, Badea R, Jung KS, Marcellin P, Filice C, Mahadeva S, Wong GL, Crotty P, Masaki K, Bojunga J, Bedossa P, Keim V, Wiegand J (2017) Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis. J Hepatol 66(5):1022\u20131030. https:\/\/doi.org\/10.1016\/j.jhep.2016.12.022","journal-title":"J Hepatol"},{"issue":"7","key":"2988_CR28","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1210\/jc.2011-0385","volume":"96","author":"MF Holick","year":"2011","unstructured":"Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, Weaver CM (2011) Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96(7):1911\u20131930. https:\/\/doi.org\/10.1210\/jc.2011-0385","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2988_CR29","doi-asserted-by":"publisher","first-page":"90","DOI":"10.12290\/xhyxzz.2024-0918","volume":"16","author":"Department of Medical Administratio","year":"2025","unstructured":"Department of Medical Administration, National Health Commission of the People\u2019s Republic of China (2025) Chinese guidelines for the clinical management of obesity (2024 Edition). Med J Peking Union Med Coll Hosp 16(1):90\u2013108. https:\/\/doi.org\/10.12290\/xhyxzz.2024-0918","journal-title":"Med J Peking Union Med Coll Hosp"},{"issue":"5","key":"2988_CR30","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1136\/gutjnl-2021-324243","volume":"71","author":"FE M\u00f3zes","year":"2022","unstructured":"M\u00f3zes FE, Lee JA, Selvaraj EA, Jayaswal ANA, Trauner M, Boursier J, Fournier C, Staufer K, Stauber RE, Bugianesi E, Younes R, Gaia S, Lup\u0219or-Platon M, Petta S, Shima T, Okanoue T, Mahadeva S, Chan WK, Eddowes PJ, Hirschfield GM, Newsome PN, Wong VW, de Ledinghen V, Fan J, Shen F, Cobbold JF, Sumida Y, Okajima A, Schattenberg JM, Labenz C, Kim W, Lee MS, Wiegand J, Karlas T, Y\u0131lmaz Y, Aithal GP, Palaniyappan N, Cassinotto C, Aggarwal S, Garg H, Ooi GJ, Nakajima A, Yoneda M, Ziol M, Barget N, Geier A, Tuthill T, Brosnan MJ, Anstee QM, Neubauer S, Harrison SA, Bossuyt PM, Pavlides M (2022) Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysis. Gut 71(5):1006\u20131019. https:\/\/doi.org\/10.1136\/gutjnl-2021-324243","journal-title":"Gut"},{"issue":"5","key":"2988_CR31","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1097\/hep.0000000000000323","volume":"77","author":"ME Rinella","year":"2023","unstructured":"Rinella ME, Neuschwander-Tetri BA, Siddiqui MS, Abdelmalek MF, Caldwell S, Barb D, Kleiner DE, Loomba R (2023) AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease. Hepatology 77(5):1797\u20131835. https:\/\/doi.org\/10.1097\/hep.0000000000000323","journal-title":"Hepatology"},{"issue":"10","key":"2988_CR32","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1016\/j.cgh.2009.05.033","volume":"7","author":"AG Shah","year":"2009","unstructured":"Shah AG, Lydecker A, Murray K, Tetri BN, Contos MJ, Sanyal AJ (2009) Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol 7(10):1104\u20131112. https:\/\/doi.org\/10.1016\/j.cgh.2009.05.033","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"11","key":"2988_CR33","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1111\/dom.14129","volume":"22","author":"V Lukenda Zanko","year":"2020","unstructured":"Lukenda Zanko V, Domislovic V, Trkulja V, Krznaric-Zrnic I, Turk-Wensveen T, Krznaric Z, Filipec Kanizaj T, Radic-Kristo D, Bilic-Zulle L, Orlic L, Dinjar-Kujundzic P, Poropat G, Stimac D, Hauser G, Mikolasevic I (2020) Vitamin D for treatment of non-alcoholic fatty liver disease detected by transient elastography: A randomized, double-blind, placebo-controlled trial. Diabetes Obes Metab 22(11):2097\u20132106. https:\/\/doi.org\/10.1111\/dom.14129","journal-title":"Diabetes Obes Metab"},{"issue":"3","key":"2988_CR34","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1111\/apt.12377","volume":"38","author":"M Eliades","year":"2013","unstructured":"Eliades M, Spyrou E, Agrawal N, Lazo M, Brancati FL, Potter JJ, Koteish AA, Clark JM, Guallar E, Hernaez R (2013) Meta-analysis: vitamin D and non-alcoholic fatty liver disease. Aliment Pharmacol Ther 38(3):246\u2013254. https:\/\/doi.org\/10.1111\/apt.12377","journal-title":"Aliment Pharmacol Ther"},{"issue":"9","key":"2988_CR35","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1038\/aps.2014.48","volume":"35","author":"YP Hao","year":"2014","unstructured":"Hao YP, Ma XJ, Luo YQ, Ni J, Dou JX, Hu YQ, Zhu JA, Bao YQ, Jia WP (2014) Serum vitamin D is associated with non-alcoholic fatty liver disease in Chinese males with normal weight and liver enzymes. Acta Pharmacol Sin 35(9):1150\u20131156. https:\/\/doi.org\/10.1038\/aps.2014.48","journal-title":"Acta Pharmacol Sin"},{"issue":"11","key":"2988_CR36","doi-asserted-by":"publisher","first-page":"3042","DOI":"10.1080\/10408398.2020.1862753","volume":"62","author":"MR Meza-Meza","year":"2022","unstructured":"Meza-Meza MR, Ruiz-Ballesteros AI, de la Cruz-Mosso U (2022) Functional effects of vitamin D: From nutrient to immunomodulator. Crit Rev Food Sci Nutr 62(11):3042\u20133062. https:\/\/doi.org\/10.1080\/10408398.2020.1862753","journal-title":"Crit Rev Food Sci Nutr"},{"issue":"4","key":"2988_CR37","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1002\/hep.24737","volume":"55","author":"CL Roth","year":"2012","unstructured":"Roth CL, Elfers CT, Figlewicz DP, Melhorn SJ, Morton GJ, Hoofnagle A, Yeh MM, Nelson JE, Kowdley KV (2012) Vitamin D deficiency in obese rats exacerbates nonalcoholic fatty liver disease and increases hepatic resistin and Toll-like receptor activation. Hepatology 55(4):1103\u20131111. https:\/\/doi.org\/10.1002\/hep.24737","journal-title":"Hepatology"},{"issue":"1","key":"2988_CR38","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1093\/ajcn\/85.1.54","volume":"85","author":"GC Major","year":"2007","unstructured":"Major GC, Alarie F, Dor\u00e9 J, Phouttama S, Tremblay A (2007) Supplementation with calcium\u2009+\u2009vitamin D enhances the beneficial effect of weight loss on plasma lipid and lipoprotein concentrations. Am J Clin Nutr 85(1):54\u201359. https:\/\/doi.org\/10.1093\/ajcn\/85.1.54","journal-title":"Am J Clin Nutr"},{"issue":"2","key":"2988_CR39","doi-asserted-by":"publisher","first-page":"279","DOI":"10.3945\/ajcn.114.090290","volume":"101","author":"AM Verreijen","year":"2015","unstructured":"Verreijen AM, Verlaan S, Engberink MF, Swinkels S, de Vogel-van den Bosch J, Weijs PJ (2015) A high whey protein-, leucine-, and vitamin D-enriched supplement preserves muscle mass during intentional weight loss in obese older adults: a double-blind randomized controlled trial. Am J Clin Nutr 101(2):279\u2013286. https:\/\/doi.org\/10.3945\/ajcn.114.090290","journal-title":"Am J Clin Nutr"},{"key":"2988_CR40","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s12916-016-0638-y","volume":"14","author":"I Barchetta","year":"2016","unstructured":"Barchetta I, Del Ben M, Angelico F, Di Martino M, Fraioli A, La Torre G, Saulle R, Perri L, Morini S, Tiberti C, Bertoccini L, Cimini FA, Panimolle F, Catalano C, Baroni MG, Cavallo MG (2016) No effects of oral vitamin D supplementation on non-alcoholic fatty liver disease in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial. BMC Med 14:92. https:\/\/doi.org\/10.1186\/s12916-016-0638-y","journal-title":"BMC Med"},{"issue":"4","key":"2988_CR41","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1136\/gutjnl-2015-310417","volume":"65","author":"MT Kitson","year":"2016","unstructured":"Kitson MT, Pham A, Gordon A, Kemp W, Roberts SK (2016) High-dose vitamin D supplementation and liver histology in NASH. Gut 65(4):717\u2013718. https:\/\/doi.org\/10.1136\/gutjnl-2015-310417","journal-title":"Gut"},{"issue":"1","key":"2988_CR42","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/apt.15298","volume":"50","author":"F Shen","year":"2019","unstructured":"Shen F, Mi Y-Q, Xu L, Liu Y-G, Wang X-Y, Pan Q, Zhang R-N, Hu X-Q, Xu L-M, Fan J-G (2019) Moderate to severe hepatic steatosis leads to overestimation of liver stiffness measurement in chronic hepatitis B patients without significant fibrosis. Aliment Pharmacol Ther 50(1):93\u2013102. https:\/\/doi.org\/10.1111\/apt.15298","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"2988_CR43","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1002\/hep.28843","volume":"65","author":"S Petta","year":"2017","unstructured":"Petta S, Wong VW-S, Camm\u00e0 C, Hiriart J-B, Wong GL-H, Marra F, Vergniol J, Chan AW-H, Di Marco V, Merrouche W, Chan HL-Y, Barbara M, Le-Bail B, Arena U, Crax\u00ec A, de Ledinghen V (2017) Improved noninvasive prediction of liver fibrosis by liver stiffness measurement in patients with nonalcoholic fatty liver disease accounting for controlled attenuation parameter values. Hepatology 65(4):1145\u20131155. https:\/\/doi.org\/10.1002\/hep.28843","journal-title":"Hepatology"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-026-02988-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-026-02988-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-026-02988-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T22:01:13Z","timestamp":1793397673000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-026-02988-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,20]]},"references-count":43,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2026,11]]}},"alternative-id":["2988"],"URL":"https:\/\/doi.org\/10.1007\/s40618-026-02988-z","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,20]]},"assertion":[{"value":"27 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors affirm that all participants provided informed consent for publication of the data.","order":1,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors report no conflicts of interest.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. The research protocol received ethical approval from the Ethics Committee of the Tianjin Union Medical Center (NO. 2021C06).","order":4,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}